Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
-term, full-time position for 2 years. The School of Electrical and Mechanical Engineering (EME)is seeking a highly motivated and skilled Postdoctoral Researcher (Atomic, Molecular, and Optical Physics
-
to $131,335 per annum plus an employer contribution of 17% Superannuation applies. Fixed-term, full-time position for 2 years. The School of Electrical and Mechanical Engineering (EME)is seeking a highly
-
mechanisms and identify potential treatments for ALS/MND and FTD, with a focus on novel pathogenic biochemical pathways and new therapeutic avenues. The incumbent may use techniques including surgery, AAVs
-
passionate and driven postdoctoral researcher with relevant expertise in sex hormone receptor and more broadly transcription factor biology to build on our recent advances in harnessing the natural antagonism
-
mechanisms and identify potential treatments for ALS/MND and FTD, with a focus on novel pathogenic biochemical pathways and new therapeutic avenues. The incumbent may use techniques including surgery, AAVs
-
Project entitled "Stoichiometric flexibility shapes microbial function and community assembly." We will reveal how change in elemental stoichiometry of cells (e.g. via intracellular storage physiology
-
immunogenomics, including the understanding of immune cell types, pathways, and mechanisms, especially in the context of cancer. The path to Adelaide University We are on an exciting path to Adelaide University as
-
of cell biology Familiarity with immunogenomics, including the understanding of immune cell types, pathways, and mechanisms, especially in the context of cancer. The path to Adelaide University We
-
national and international partners https://www.amtarhub.com.au/about/ . In this role, you will develop, prepare, and characterise metal ion chelators as key components of targeted radiopharmaceuticals, and
-
the microbiota can be leveraged to improve health outcomes. Our recent work has identified the gut microbiota as an important factor in cancer immunotherapy outcomes. This role represents an exciting